Pittsburgh Business Times – UPMC and GE Healthcare, a division of General Electric Co. (NYSE: GE), partnered in 2008 to create Omnyx, a company with the goal of creating the first digital pathology system approved by the U.S. Food and Drug Administration for clinical use, which could potentially bring cancer diagnosis into the 21st Century. Now, seven years later, they may be getting closer.
Recent Posts
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Read More →
Werewolf Therapeutics launches as publicly traded company
Werewolf Therapeutics, a biopharmaceutical company pioneering the development of therapeutics to stimulate the body’s immune …
Read More →
The Intersection of Value and AI: Where Machines Can Make a Difference
Upcoming CCM panel discussion features experts from UPMC, Vanderbilt, NCQA, and Astrata on the future of artificial intelligence in health care
Read More →